Legal & Regulatory
U.S. approval of Merck cancer immunotherapy expected soon
U.S. regulators are likely to approve Merck & Co's highly anticipated immuno-oncology drug, pembrolizumab, as a treatment for melanoma well ahead of a late October deadline, according to three sources familiar with the situation.
Rocket Internet and Zalando to unveil listing plans in Sept: sources
German venture capital firm Rocket Internet and Zalando, Europe's biggest specialist online fashion retailer, are both on the brink of announcing plans to list on the Frankfurt stock exchange, several sources with knowledge of the matter said.
Taiwan's Wei family to buy cable TV operator CNS for $2.4 billion: source
Taiwan's Wei family has agreed to buy China Network Systems (CNS), the nation's biggest cable TV operator, for about $2.4 billion including debt from private equity firm MBK Partners, a person with direct knowledge of the matter told Reuters on Sunday.
Sony PlayStation Network taken down by attack
Sony Corp (6758.T) said on Sunday its PlayStation Network was taken down by a denial of service-style attack and the FBI was investigating the diversion of a flight carrying a top Sony executive amid reports of a claim that explosives were on board.